Results 131 to 140 of about 418,298 (339)

Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group [PDF]

, 1995
C.M.A. Swanink, Jan H. Vercoulen, Gijs Bleijenberg, J.F.M. Fennis, Joep M.D. Galama, J.W.M. van der Meer   +5 more
openalex   +1 more source

Safety and Pharmacokinetics of Long‐Acting Monoclonal Antibodies Tixagevimab and Cilgavimab (AZD7442) in a China Phase 2 Study and Evaluation of Asian Race Effect

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Safety, pharmacokinetics, and impact of race of pharmacokinetics on monoclonal antibodies tixagevimab and cilgavimab (AZD7442) were assessed in Chinese adult participants in a Phase 2, randomized, double‐blind, placebo‐controlled trial. In total, 272 participants were randomized 3:1 to a single intravenous dose of 600 mg AZD7442 or placebo and
Jing Zhang, Huixia Zhang, Yajuan Zhang, Shuyuan Liu, Xiaoyun Ge, Haiyue Zhang, Yunfei Li, Cecil Chi‐Keung Chen, Oleg Stepanov, Weifeng Tang, Wenhong Zhang   +10 more
wiley   +1 more source

Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome [PDF]

, 1997
Sudhir Gupta, Sudeepta Aggarwal, Darryl M. See, Arnold Starr   +3 more
openalex   +1 more source

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double‐Blind, Placebo‐Controlled Study

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Bexicaserin (LP352) is a selective superagonist of the 5‐hydroxytryptamine 2C (5‐HT2C) receptor currently in development for the treatment of seizures that arise from developmental and epileptic encephalopathies. This phase 1, double‐blind, placebo‐controlled multiple ascending dose (MAD) study assessed the safety, tolerability, and ...
Jonathan Williams, Rosa Chan, Chad Orevillo, Gale O'Connell, Dewey McLin, Shikha Polega, Nuggehally R. Srinivas, Randall Kaye   +7 more
wiley   +1 more source

Cross-Sectional Study Evaluating the Role of Autonomic Nervous System Functional Diagnostics in Differentiating Post-Infectious Syndromes: Post-COVID Syndrome, Chronic Fatigue Syndrome, and Lyme Disease

Biomedicines
Background/Objectives: Post-infectious syndromes, including Post-COVID syndrome, Chronic Fatigue Syndrome, and late-stage Lyme disease, are associated with overlapping clinical features and autonomic dysfunction.
Branislav Milovanovic, Nikola Markovic, Masa Petrovic, Vasko Zugic, Milijana Ostojic, Milovan Bojic   +5 more
doaj   +1 more source

Absence of evidence of Borna disease virus infection in Swedish patients with Chronic Fatigue Syndrome [PDF]

, 1999
Birgitta Evengård, Thomas Briese, Gudrun Lindh, Simon Lee, W. Ian Lipkin   +4 more
openalex   +1 more source

Responsible Work, Resilient Workforce: A Corporate Social Responsibility Knowledge‐Based Perspective

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The purpose of this research is to demonstrate the role of employee coping in determining the effect of workaholism on burnout. This study utilized a survey approach to collect information from a varied cohort of teachers encompassing individuals employed in private sector educational institutions, following a time‐lagged approach.
Roberto Cerchione, Giuseppe Liccardo, Shahid Rasool, Hira Waheed, Muhammad Zeshan   +4 more
wiley   +1 more source

Possible Correlation between Borna Disease Virus Infection and Japanese Patients with Chronic Fatigue Syndrome [PDF]

, 1996
Teruo Kitani, Hirohiko Kuratsune, Isao Fuke, Y. Nakamura, Takaaki Nakaya, Sayumi Asahi, Minoru Tobiume, Kouzi Yamaguti, Takashi Machii, Reiko Inagi, Koichi Yamanishi, Kazuyoshi Ikuta   +11 more
openalex   +1 more source

Predictors and Mediators of Outcome of a Focussed, Programme Led Intervention for Young People With Eating Disorders

International Journal of Eating Disorders, EarlyView.
ABSTRACT Background Focussed and programme‐led interventions have been of increased interest in the eating disorders (EDs) field as a potential solution to barriers in accessing timely, effective treatments. Little is known about the mechanisms through which these treatments work or for whom they are most suitable.
Daniel Wilson, Renata A. Mendes, Natalie J. Loxton   +2 more
wiley   +1 more source

Prognosis in chronic fatigue syndrome: a prospective study on the natural course. [PDF]

, 1996
Jan H. Vercoulen, C.M.A. Swanink, J.F.M. Fennis, J M Galama, J W van der Meer, Gijs Bleijenberg   +5 more
openalex   +1 more source